(Q43615162)

25 November 2017

title

Induction of acquired factor IX inhibitors in cynomolgus monkey (Macaca fascicularis): a new primate model of hemophilia B. (English)

1 reference

25 November 2017

0 references

coagulation factor IX

0 references

0 references

0 references

Tomokiyo K

1

1 reference

25 November 2017

Teshima K

2

1 reference

25 November 2017

Nakatomi Y

3

1 reference

25 November 2017

Watanabe T

4

1 reference

25 November 2017

Mizuguchi J

5

1 reference

25 November 2017

Nozaki C

6

1 reference

25 November 2017

Nakagaki T

7

1 reference

25 November 2017

Miyamoto S

8

1 reference

25 November 2017

Funatsu A

9

1 reference

25 November 2017

Iwanaga S

10

1 reference

25 November 2017

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

102

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

363-374

1 reference

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

A human factor VIIa concentrate and its effects in the hemophilic A dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Factor X activating enzyme from Russell's viper venom: isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Bovine factor IX (Christmas factor).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

1 reference

7 January 2021

Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Sequence-specific 1H NMR assignments, secondary structure, and location of the calcium binding site in the first epidermal growth factor like domain of blood coagulation factor IX.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

Characterization of a rabbit factor IX cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2801%2900253-5

7 January 2021

10.1016/S0049-3848(01)00253-5

Identifiers

DOI

1 reference

25 November 2017

1 reference